Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue. The rally was further supported by a Rs 149-crore capex plan to add 405 KL of capacity for its CDMO and intermediate businesses.
Aarti Pharmalabs shares surged 33.4% in just two days following the release of its strong June-quarter results. The company's consolidated profit skyrocketed 65.4% year-on-year, while revenue grew 38.7%. This impressive financial performance clearly impressed investors, sending the stock price soaring.
Written by urgent.news from The Economic Times - Top News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
